abstract |
The present invention relates to heterocyclic compounds and methods that may be useful as inhibitors of transcriptional activating proteins such as CBP and P300 for the treatment or prevention of diseases such as proliferative diseases, inflammatory disorders, autoimmune diseases, and fibrotic diseases. |